Hypoxia-induced tumor malignancy and drug resistance: Role of microRNAs

研究成果: Review article

8 引文 (Scopus)

摘要

Hypoxia is an intricate microenvironment associated with aggressiveness and chemoresistance of a variety of solid tumors. Hypoxia-inducible factors (HIFs) regulate downstream target genes that render cancer cells capacity to adapt to the hostile, low-oxygen stress for survival. HIF has been estimated to regulate more than 5% of total human genes. The HIF-regulated gene network has been shown to be associated with resistance to chemotherapy, metastasis, tumor recurrence, and reduced overall survival rate. With the increasing findings that microRNAs (miRNAs) are aberrantly expressed under hypoxia, which participate positively or negatively in regulating hypoxia-related genes, the signaling pathway of hypoxia becomes more and more complicated. Based on the roles of miRNAs in tumor development and drug resistance, the potential of targeting miRNAs as a therapeutic regimen has been emphasized recently. Therefore, understanding the regulation and functions of miRNAs in cancer cells will provide us with useful information for designing more efficacious treatment regimens. In this article, we will review the biological kinship of hypoxia and hypoxia-regulated miRNAs in cancer malignancy and drug resistance.

原文English
頁(從 - 到)1-11
頁數11
期刊Biomarkers and Genomic Medicine
6
發行號1
DOIs
出版狀態Published - 2014 一月 1

指紋

MicroRNAs
Drug Resistance
Tumors
Genes
Pharmaceutical Preparations
Neoplasms
Cells
Chemotherapy
Oxygen
Hypoxia
Tumor Hypoxia
Gene Regulatory Networks
Neoplasm Genes
Neoplasm Metastasis
Recurrence
Drug Therapy
Survival
Therapeutics

All Science Journal Classification (ASJC) codes

  • Biomedical Engineering
  • Biochemistry, Genetics and Molecular Biology(all)
  • Drug Discovery

引用此文

@article{1043ec829623428686b88c3792d941a5,
title = "Hypoxia-induced tumor malignancy and drug resistance: Role of microRNAs",
abstract = "Hypoxia is an intricate microenvironment associated with aggressiveness and chemoresistance of a variety of solid tumors. Hypoxia-inducible factors (HIFs) regulate downstream target genes that render cancer cells capacity to adapt to the hostile, low-oxygen stress for survival. HIF has been estimated to regulate more than 5{\%} of total human genes. The HIF-regulated gene network has been shown to be associated with resistance to chemotherapy, metastasis, tumor recurrence, and reduced overall survival rate. With the increasing findings that microRNAs (miRNAs) are aberrantly expressed under hypoxia, which participate positively or negatively in regulating hypoxia-related genes, the signaling pathway of hypoxia becomes more and more complicated. Based on the roles of miRNAs in tumor development and drug resistance, the potential of targeting miRNAs as a therapeutic regimen has been emphasized recently. Therefore, understanding the regulation and functions of miRNAs in cancer cells will provide us with useful information for designing more efficacious treatment regimens. In this article, we will review the biological kinship of hypoxia and hypoxia-regulated miRNAs in cancer malignancy and drug resistance.",
author = "Liao, {Wan Lin} and Shao-Chieh Lin and Hsiao-Fang Sun and Shaw-Jenq Tsai",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.bgm.2014.01.003",
language = "English",
volume = "6",
pages = "1--11",
journal = "Genomic Medicine, Biomarkers, and Health Sciences",
issn = "2214-0247",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Hypoxia-induced tumor malignancy and drug resistance

T2 - Role of microRNAs

AU - Liao, Wan Lin

AU - Lin, Shao-Chieh

AU - Sun, Hsiao-Fang

AU - Tsai, Shaw-Jenq

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Hypoxia is an intricate microenvironment associated with aggressiveness and chemoresistance of a variety of solid tumors. Hypoxia-inducible factors (HIFs) regulate downstream target genes that render cancer cells capacity to adapt to the hostile, low-oxygen stress for survival. HIF has been estimated to regulate more than 5% of total human genes. The HIF-regulated gene network has been shown to be associated with resistance to chemotherapy, metastasis, tumor recurrence, and reduced overall survival rate. With the increasing findings that microRNAs (miRNAs) are aberrantly expressed under hypoxia, which participate positively or negatively in regulating hypoxia-related genes, the signaling pathway of hypoxia becomes more and more complicated. Based on the roles of miRNAs in tumor development and drug resistance, the potential of targeting miRNAs as a therapeutic regimen has been emphasized recently. Therefore, understanding the regulation and functions of miRNAs in cancer cells will provide us with useful information for designing more efficacious treatment regimens. In this article, we will review the biological kinship of hypoxia and hypoxia-regulated miRNAs in cancer malignancy and drug resistance.

AB - Hypoxia is an intricate microenvironment associated with aggressiveness and chemoresistance of a variety of solid tumors. Hypoxia-inducible factors (HIFs) regulate downstream target genes that render cancer cells capacity to adapt to the hostile, low-oxygen stress for survival. HIF has been estimated to regulate more than 5% of total human genes. The HIF-regulated gene network has been shown to be associated with resistance to chemotherapy, metastasis, tumor recurrence, and reduced overall survival rate. With the increasing findings that microRNAs (miRNAs) are aberrantly expressed under hypoxia, which participate positively or negatively in regulating hypoxia-related genes, the signaling pathway of hypoxia becomes more and more complicated. Based on the roles of miRNAs in tumor development and drug resistance, the potential of targeting miRNAs as a therapeutic regimen has been emphasized recently. Therefore, understanding the regulation and functions of miRNAs in cancer cells will provide us with useful information for designing more efficacious treatment regimens. In this article, we will review the biological kinship of hypoxia and hypoxia-regulated miRNAs in cancer malignancy and drug resistance.

UR - http://www.scopus.com/inward/record.url?scp=84897959821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897959821&partnerID=8YFLogxK

U2 - 10.1016/j.bgm.2014.01.003

DO - 10.1016/j.bgm.2014.01.003

M3 - Review article

AN - SCOPUS:84897959821

VL - 6

SP - 1

EP - 11

JO - Genomic Medicine, Biomarkers, and Health Sciences

JF - Genomic Medicine, Biomarkers, and Health Sciences

SN - 2214-0247

IS - 1

ER -